; Global Atrial Fibrillation Market 2010–2014
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Global Atrial Fibrillation Market 2010–2014

VIEWS: 6 PAGES: 35

TechNavio’s analysts forecast the Global Atrial Fibrillation market to grow at a CAGR of 14 percent over the period 2010–2014. One of the key factors contributing to this market growth is the emergence of new anti-arrhythmic and anti-coagulant agents for atrial fibrillation. The Global Atrial Fibrillation market has also been witnessing an increase in the number of clinical trials of atrial fibrillation devices and drugs. However, the unorganized market in the APAC region could pose a challenge to the growth of this market. TechNavio’s report, Global Atrial Fibrillation Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Atrial Fibrillation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include St. Jude Medical Inc., Boston Scientific Corp., Biosense Webster Inc., C.R. Bard Inc., and Medtronic Inc. Key questions answered in this report: What will the market size be in 2014 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors?

More Info
  • pg 1
									2010-2014   Global Atrial Fibrillation Market




                                  technavio insights
2010-2014             Global Atrial Fibrillation Market




            CONTENTS


            01. Executive Summary ..............................................1

            02. Introduction ...........................................................2
            03. Market Coverage .................................................4

            04. Market Landscape ................................................6

            05. Vendor Landscape ...............................................9

            06. Buying Criteria .....................................................12
            07. Market Growth Drivers ........................................13

            08. Drivers and their Impact .....................................16

            09. Market Challenges .............................................17

            10. Market Trends ......................................................19

            11. Key Vendor Analysis ...........................................21
            11.1 St. Jude Medical Inc. .......................................................... 21

            11.2 Boston Scientific Corp. ....................................................... 23

            11.3 Biosense Webster Inc. ......................................................... 25

            11.4 C.R. Bard Inc. ....................................................................... 27

            11.5 Medtronic Inc. ..................................................................... 29

            12. Other Reports in this Series .................................31




2010-2014                                                       Global Atrial Fibrillation Market
2010-2014          Global Atrial Fibrillation Market




            EXHIBITS

            Exhibit 1: Global Atrial Fibrillation Market 2010–2014 (US$
                       billions) ....................................................................................7

            Exhibit 2: Global            Atrial          Fibrillation            Market             by
                       Geographical Segmentation 2010 ....................................8

            Exhibit 3: Global Atrial Fibrillation Market by Vendor
                       Segmentation 2010 ............................................................10




2010-2014                                                           Global Atrial Fibrillation Market
Global Atrial Fibrillation Market                                                                       1

      01. Executive Summary
                             2010: US$2.1 billion
        Market Size
                             2014: US$3.6 billion

        Growth Rate          14 percent CAGR

                             The Americas
        Key Geographies      EMEA
                             APAC

                             Hospitals
        Key Customer         Healthcare Centers
        Segments             Pharmacy Stores
                             Patients

                             EMA Recommends Restricted Use of Multaq
                             Approval of Xarelto by US FDA
        Trends               Increase in Number of Clinical Trials of Atrial Fibrillation Devices
                             and Drugs
                             Increase in Mergers and Acquisitions

                             Paradigm Shift from Conventional Treatments to New
                             Technologies
                             Significant Increase in Sales of Eliquis
        Drivers
                             Emergence of New Antiarrhythmic and Anticoagulant Agents
                             for Atrial Fibrillation
                             Increasing Aging and Diabetic Population Worldwide

                             Unorganized Market in the APAC Region
        Challenges           Negative Effect of Global Economic Recession
                             Challenges for Small Vendors

                             Cost-effectiveness
                             Safety
        Key Customer Needs
                             Offerings
                             Availability

                             St. Jude Medical Inc.
                             Boston Scientific Corp.
        Key Vendors          Biosense Webster Inc.
                             C.R. Bard Inc.
                             Medtronic Inc.




2010-2014                                                                Global Atrial Fibrillation Market
Global Atrial Fibrillation Market                                                                                 2

      02. Introduction
      Atrial fibrillation is a rapid and inconsistent rhythm that occurs in the heart. People suffering from
      atrial fibrillation may experience fatigue and shortness of breath, which tend to increase the risk
      of stroke. Atrial fibrillation is one of the most common heart rhythm disorders worldwide. Effective
      treatment for atrial fibrillation depends on rate control strategies, maintenance of sinus rhythm
      with antiarrhythmic drugs and catheter ablation, and antiembolic therapy. Over the forecast
      period, more than 8.5 million people worldwide are expected to suffer from atrial fibrillation.

      The Global Atrial Fibrillation market is growing at a steady rate, but mainly only in developed
      countries. However, this market is growing at a relatively slow rate in developing countries.
      Currently, the markets 
								
To top